和铂医药-B(02142.HK) 披露业务进展及更新,预期截至2024年12月31日止年度,将录得溢利介乎730万元至2,200万元人民币。另外,公司的现金溢利(经营现金净流入)达到2.2亿元人民币的历史新高。
公布日期 | 派息事项 | 派息内容 |
---|---|---|
2024/08/28 | 中期业绩 | 无派息 |
2024/03/28 | 末期业绩 | 无派息 |
2023/08/28 | 中期业绩 | 无派息 |
2023/03/29 | 末期业绩 | 无派息 |
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.